Federal Circuit

The Federal Circuit upheld the PTAB’s obviousness ruling and denial of substitute claims for a railcar anomaly-monitoring patent.

The Federal Circuit affirmed that Nexus Pharmaceuticals’ generic minocycline product infringes Melinta’s patent covering a magnesium-containing antibiotic formulation that reduces injection-site hemolysis.

The Federal Circuit vacated an $11.5 million patent infringement verdict against ecobee, holding that a single-question verdict form covering four patents was improper and that the jury was not properly instructed on the abstract idea under Alice step two.

The Federal Circuit reversed a PTAB decision that had upheld claims of a spinal implant patent, finding the Board misconstrued the term ‘complementary with one another’ and that the claims are obvious under the correct construction.

The Federal Circuit vacated the PTAB’s decision upholding an e-learning patent, finding the Board improperly dismissed expert testimony on obviousness as ‘conclusory’ when it addressed a simple design choice of reordering two steps.

The Federal Circuit affirmed judgment as a matter of law that DISH Network’s AutoHop commercial-skipping feature does not infringe ClearPlay’s content-filtering patents, finding that AutoHop uses categorical on/off settings rather than directly disabling individual navigation objects.

The Federal Circuit affirmed the PTAB’s finding that all 17 claims of Pictometry’s patent on measuring roofs from aerial imagery are unpatentable as obvious over prior art combining roof-measurement and marker-locking references.

The Federal Circuit affirmed the PTAB’s finding that all claims of a synchronized-browsing patent were unpatentable as obvious, rejecting the patent holder’s bid to narrowly construe the key claim term “web browsing interaction data.”

The Federal Circuit affirmed that Lupin’s generic tolvaptan manufacturing process does not infringe Otsuka’s patents and that certain synthesis method claims are obvious, clearing the way for a generic version of the kidney disease drug JYNARQUE®.

The Federal Circuit reversed a dismissal for lack of standing, holding that a patent owner who grants an exclusive license but retains the right to sue, a sublicensing veto, and royalty interests retains a sufficient exclusionary right for Article III standing.

In a companion case to ALM Holding v. Zydex, the Federal Circuit held that Medtronic Ireland retained Article III standing to assert patent infringement counterclaims despite licensing exclusive rights to an affiliate, because it kept the right to sue, sublicensing veto, and royalty interests.

In a precedential opinion, the Federal Circuit reversed a Delaware district court’s dismissal for lack of standing, holding that patent owners who retain the right to sue for infringement, a sublicensing veto, and royalty interests maintain Article III standing even after granting a broad excl

The full Federal Circuit denied en banc rehearing of its February 2026 panel decision affirming a $71.4 million verdict for infringement of Willis Electric’s pre-lit Christmas tree connector patent, rejecting Polygroup’s challenge to the damages expert methodology.

The Federal Circuit affirmed dismissal of a patent infringement case involving a unified electronic banking system, finding surviving claims obvious in light of an IPR outcome, but reversed both the exceptional-case attorney fee award and sanctions against counsel, holding that mere invalidity is in

The Federal Circuit affirmed that Actelion’s patent claims requiring a bulk solution with ‘a pH of 13 or higher’ refer to pH measured at standard temperature (25±2°C), not at the solution’s actual operating temperature, finding no literal or equivalent infringement by Mylan&#

The Federal Circuit affirmed that Samsung’s 2012 sales agreement with Finelite unambiguously incorporated a full contract of sale that limited Samsung’s indemnification obligations to Hong Kong — where title to LED chips passed — leaving Finelite without indemnity coverage for U.S. paten

The Federal Circuit affirmed the PTAB’s finding that claims of Universal Electronics’ remote control codeset patent (U.S. Patent No. 9,847,083) are unpatentable as obvious, agreeing with the Board’s broad construction of ‘protocol and formatting information’ as ‘i

The Federal Circuit affirmed the dismissal of a pro se challenge to the PTO’s denial of micro-entity status, holding that inventors who admit they are obligated to assign their patent application lack Article III standing to contest the associated fee determination.